Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 6, Issue 20

October 25 2022

In this Issue

STIMULUS REPORT
CLINICAL TRIALS AND OBSERVATIONS
HEALTH SERVICES AND OUTCOMES
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
RESEARCH LETTERS

STIMULUS REPORT

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance

Piers Blombery,Ella R. Thompson,Thomas E. Lew,Ing Soo Tiong,Rory Bennett,Chan Y. Cheah,Katharine Louise Lewis,Sasanka M. Handunnetti,Chloe Pek Sang Tang,Andrew Roberts,John F. Seymour,Constantine S. Tam

View Articletitled, Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance

Supplemental data

Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro

Qiuchen Guo,Michael W. Malloy,Harvey G. Roweth,Sandra S. McAllister,Joseph E. Italiano, Jr.,Elisabeth M. Battinelli

View Articletitled, Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro

Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
Clinical Trials & Observations

Ibrahim M. Idris,Akib Abba,Jamil A. Galadanci,Sani A. Aji,Atiku U. Jibrilla,Mark Rodeghier,Adetola Kassim,Arthur L. Burnett,Michael R. DeBaun

View Articletitled, Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis

Supplemental data

HEALTH SERVICES AND OUTCOMES

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

Elisabet Viayna,Eric A. Gehrie,Christopher Blanchette,Geralyn M. Meny,Ghislain Noumsi,Maria Huber,M. Chris Runken

View Articletitled, Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma

Anas Younes,John M. Burke,Catherine Diefenbach,Silvia Ferrari,Cyrus Khan,Jeff P. Sharman,Monica Tani,Chaitra Ujjani,Umberto Vitolo,Sam Yuen,Aparna Raval,Mahesh Shivhare,Tina G. Nielsen,Gila Sellam,Michael Gilbertson

View Articletitled, Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma

Supplemental data

LYMPHOID NEOPLASIA

MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

Serena Matis,Anna Grazia Recchia,Monica Colombo,Martina Cardillo,Marina Fabbi,Katia Todoerti,Sabrina Bossio,Sonia Fabris,Valeria Cancila,Rosanna Massara,Daniele Reverberi,Laura Emionite,Michele Cilli,Giannamaria Cerruti,Sandra Salvi,Paola Bet,Simona Pigozzi,Roberto Fiocca,Adalberto Ibatici,Emanuele Angelucci,Massimo Gentile,Paola Monti,Paola Menichini,Gilberto Fronza,Federica Torricelli,Alessia Ciarrocchi,Antonino Neri,Franco Fais,Claudio Tripodo,Fortunato Morabito,Manlio Ferrarini,Giovanna Cutrona

View Articletitled, MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

Supplemental data

ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent

Rebecca A. Luchtel,Yongmei Zhao,Ritesh K. Aggarwal,Kith Pradhan,Shahina B. Maqbool

View Articletitled, ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent

Supplemental data

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy

Max Yano,Chia Sharpe,J. Rachel Lance,Janani Ravikrishnan,Kevan Zapolnik,Xiaokui Mo,Jennifer A. Woyach,Deepa Sampath,Adam S. Kittai,Sumithira Vasu,Seema Bhat,Kerry A. Rogers,Dean A. Lee,Natarajan Muthusamy,John C. Byrd

View Articletitled, Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy

Supplemental data

MYELOID NEOPLASIA

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis

Karla Cavazos,Sheila Eswaran,Cathleen Maidlow,Fatma Keklik Karadag,Ramazan Idilman,Ilkay Idilman,Ira Miller,Jamile Shammo,Nancy Reau,Celalettin Ustun

View Articletitled, Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis

Supplemental data

RESEARCH LETTERS

Racial disparities in access to alternative donor allografts persist in the era of “donors for all”
Clinical Trials & Observations

Warren B. Fingrut,Boglarka Gyurkocza,Eric Davis,Jessica Flynn,Stephanie Chinapen,Kristine A. Naputo,Sean Quach,Christina Cho,Sergio A. Giralt,Ann A. Jakubowski,Richard J. Lin,Esperanza Papadopoulos,Miguel-Angel Perales,Doris M. Ponce,Brian C. Shaffer,Craig S. Sauter,Roni Tamari,James W. Young,Andromachi Scaradavou,Ioannis Politikos,Juliet N. Barker

View Articletitled, Racial disparities in access to alternative donor allografts persist in the era of “donors for all”

Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

Armin Ghobadi,Jack H. Landmann,Alun Carter,Matthew L. Cooper,Mehmet Emrah Selli,Jufang Chang,Matthew Baker,Christopher A. Miller,Francesca Ferraro,David Y. Chen,Amanda M. Smith,Taylor A. LaValle,Eric J. Duncavage,Justin Chou,Victor Tam,Joseph M. Benoun,Jenny Nater,Nathalie Scholler,Francesca Milletti,Remus Vezan,Adrian Bot,John M. Rossi,Nathan Singh

View Articletitled, Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

Supplemental data

Cover Image

Cover Image

Peripheral blood picture of chronic lymphocytic leukemia (CLL), analyzed by microscope at 1000x original magnification. ID 161895256 © Jarun011 | Dreamstime.com
Front Matter
Editorial Board

All Issues

Advertisement intended for health care professionals

Email alerts

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read
Most Cited

Time to revisit reduced-dose radiotherapy for PCNSL?

Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.

Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes

Retreatment of multiple myeloma with previously refractory drugs

Advertisement intended for health care professionals

Table of Contents

STIMULUS REPORT

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance

Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro

CLINICAL TRIALS AND OBSERVATIONS

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
Clinical Trials & Observations

HEALTH SERVICES AND OUTCOMES

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma

LYMPHOID NEOPLASIA

MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy

MYELOID NEOPLASIA

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis

RESEARCH LETTERS

Racial disparities in access to alternative donor allografts persist in the era of “donors for all”
Clinical Trials & Observations

Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

STIMULUS REPORT

CLINICAL TRIALS AND OBSERVATIONS

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis Clinical Trials & Observations

HEALTH SERVICES AND OUTCOMES

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

RESEARCH LETTERS

Racial disparities in access to alternative donor allografts persist in the era of “donors for all” Clinical Trials & Observations

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
Clinical Trials & Observations

Racial disparities in access to alternative donor allografts persist in the era of “donors for all”
Clinical Trials & Observations